Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 37: 1955-1967, 1991;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ekins, R. P.
Right arrow Articles by Chu, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ekins, R. P.
Right arrow Articles by Chu, F. W.

Clinical Chemistry, Vol 37, 1955-1967, Copyright © 1991 by American Association for Clinical Chemistry

Multianalyte microspot immunoassay--microanalytical "compact disk" of the future

RP Ekins and FW Chu
Department of Molecular Endocrinology, University College and Middlesex School of Medicine, London, U.K.

Throughout the 1970s, controversy centered both on immunoassay "sensitivity" per se and on the relative sensitivities of labeled antibody (Ab) and labeled analyte methods. Our theoretical studies revealed that RIA sensitivities could be surpassed only by the use of very high-specificity nonisotopic labels in "noncompetitive" designs, preferably with monoclonal antibodies. The time-resolved fluorescence methodology known as DELFIA--developed in collaboration with LKB/Wallac- -represented the first commercial "ultrasensitive" nonisotopic technique based on these theoretical insights, the same concepts being subsequently adopted in comparable methodologies relying on the use of chemiluminescent and enzyme labels. However, high-specific-activity labels also permit the development of "multianalyte" immunoassay systems combining ultrasensitivity with the simultaneous measurement of tens, hundreds, or thousands of analytes in a small biological sample. This possibility relies on simple, albeit hitherto-unexploited, physicochemical concepts. The first is that all immunoassays rely on the measurement of Ab occupancy by analyte. The second is that, provided the Ab concentration used is "vanishingly small," fractional Ab occupancy is independent of both Ab concentration and sample volume. This leads to the notion of "ratiometric" immunoassay, involving measurement of the ratio of signals (e.g., fluorescent signals) emitted by two labeled Abs, the first (a "sensor" Ab) deposited as a microspot on a solid support, the second (a "developing" Ab) directed against either occupied or unoccupied binding sites of the sensor Ab. Our preliminary studies of this approach have relied on a dual-channel scanning-laser confocal microscope, permitting microspots of area 100 microns 2 or less to be analyzed, and implying that an array of 10(6) Ab-containing microspots, each directed against a different analyte, could, in principle, be accommodated on an area of 1 cm2. Although measurement of such analyte numbers is unlikely ever to be required, the ability to analyze biological fluids for a wide spectrum of analystes is likely to transform immunodiagnostics in the next decade.


The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
J. D. McBride, F. G. Gabriel, J. Fordham, T. Kolind, G. Barcenas-Morales, D. A. Isenberg, M. Swana, P. J. Delves, T. Lund, I. A. Cree, et al.
Screening Autoantibody Profiles in Systemic Rheumatic Disease with a Diagnostic Protein Microarray That Uses a Filtration-Assisted Nanodot Array Luminometric Immunoassay (NALIA)
Clin. Chem., May 1, 2008; 54(5): 883 - 890.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J.-a. Kwon, H. Lee, K. N. Lee, K. Chae, S. Lee, D.-k. Lee, and S. Kim
High Diagnostic Accuracy of Antigen Microarray for Sensitive Detection of Hepatitis C Virus Infection
Clin. Chem., February 1, 2008; 54(2): 424 - 428.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. S. Dandy, P. Wu, and D. W. Grainger
Array feature size influences nucleic acid surface capture in DNA microarrays
PNAS, May 15, 2007; 104(20): 8223 - 8228.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. R. Lakowicz, J. Malicka, E. Matveeva, I. Gryczynski, and Z. Gryczynski
Plasmonic Technology: Novel Approach to Ultrasensitive Immunoassays
Clin. Chem., October 1, 2005; 51(10): 1914 - 1922.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. Du, M. Wu, W. Yang, G. Yuan, Y. Sun, Y. Lu, S. Zhao, Q. Du, J. Wang, S. Yang, et al.
Development of Miniaturized Competitive Immunoassays on a Protein Chip as a Screening Tool for Drugs
Clin. Chem., February 1, 2005; 51(2): 368 - 375.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. Saviranta, R. Okon, A. Brinker, M. Warashina, J. Eppinger, and B. H. Geierstanger
Evaluating Sandwich Immunoassays in Microarray Format in Terms of the Ambient Analyte Regime
Clin. Chem., October 1, 2004; 50(10): 1907 - 1920.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
N. L. Anderson and N. G. Anderson
The Human Plasma Proteome: History, Character, and Diagnostic Prospects
Mol. Cell. Proteomics, November 1, 2002; 1(11): 845 - 867.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Arcellana-Panlilio and S. M. Robbins
Cutting-edge technology: I. Global gene expression profiling using DNA microarrays
Am J Physiol Gastrointest Liver Physiol, March 1, 2002; 282(3): G397 - G402.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Wiese, Y. Belosludtsev, T. Powdrill, P. Thompson, and M. Hogan
Simultaneous Multianalyte ELISA Performed on a Microarray Platform
Clin. Chem., August 1, 2001; 47(8): 1451 - 1457.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Soukka, J. Paukkunen, H. Harma, S. Lonnberg, H. Lindroos, and T. Lovgren
Supersensitive Time-resolved Immunofluorometric Assay of Free Prostate-specific Antigen with Nanoparticle Label Technology
Clin. Chem., July 1, 2001; 47(7): 1269 - 1278.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Eriksson, M. Vehniainen, T. Jansen, V. Meretoja, P. Saviranta, K. Pettersson, and T. Lovgren
Dual-Label Time-resolved Immunofluorometric Assay of Free and Total Prostate-specific Antigen Based on Recombinant Fab Fragments
Clin. Chem., May 1, 2000; 46(5): 658 - 666.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. M. Ostroff, D. Hopkins, A. B. Haeberli, W. Baouchi, and B. Polisky
Thin Film Biosensor for Rapid Visual Detection of Nucleic Acid Targets
Clin. Chem., September 1, 1999; 45(9): 1659 - 1664.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. J. Kricka
Miniaturization of analytical systems
Clin. Chem., September 1, 1998; 44(9): 2008 - 2014.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. P. Ekins
Ligand assays: from electrophoresis to miniaturized microarrays
Clin. Chem., September 1, 1998; 44(9): 2015 - 2030.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. W. Silzel, B. Cercek, C. Dodson, T. Tsay, and R. J. Obremski
Mass-sensing, multianalyte microarray immunoassay with imaging detection
Clin. Chem., September 1, 1998; 44(9): 2036 - 2043.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Lovgren, P. Heinonen, P. Lehtinen, H. Hakala, J. Heinola, R. Harju, H. Takalo, V.-M. Mukkala, R. Schmid, H. Lonnberg, et al.
Sensitive bioaffinity assays with individual microparticles and time-resolved fluorometry
Clin. Chem., October 1, 1997; 43(10): 1937 - 1943.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Association for Clinical Chemistry.